Navigation Links
Link between chronic kidney disease and oxygen-deprived tissue
Date:12/18/2007

PHILADELPHIA- Researchers at the University of Pennsylvania School of Medicine have discovered how low-oxygen conditions can worsen chronic kidney disease (CKD). The key player is a protein called hypoxia-inducible-factor (HIF-1) that, as its name suggests, is active when the kidney does not get enough oxygen, a condition known as hypoxia. The findings appear in a December issue of the Journal of Clinical Investigation.

CKD afflicts 20 million Americans who have hypertension, atherosclerosis, diabetes, and other conditions. The kidney has less oxygen reserves than other organs to start, and CKD is associated with less capillary blood flow, reducing oxygenation even further. As CKD progresses, kidneys become full of fibrous tissue and cannot filter wastes out of blood or regulate body salt. Eventually kidney dialysis, a form of renal replacement therapy, may be needed to carry out these processes. Ultimately, the clinical goal is to optimize treatment to halt or delay the progression of CKD by better understanding its molecular underpinnings.

"Fibrosis worsens when the kidney becomes hypoxic," states lead author Volker Haase, MD, Assistant Professor of Medicine, Renal Electrolyte and Hypertension Division. "We found that HIF-1 is more stable when oxygen is in short supply and that HIF-1 causes kidney epithelial cells to regress to a less-differentiated cell type. This transition is driven by HIF-1, a protein that turns on many genes that promote the synthesis of fibrous connective tissue, thus interfering with the kidneys normal filtering function," says Haase.

The study was conducted using mice that had been engineered to turn off expression of HIF-1 (a critical subunit of HIF-1) in their kidneys. One kidney from each mouse was put under oxygen stress by obstructing the ureter, and the other kidney served as a control. As long as HIF-1a was silenced, fibrosis was reduced in the oxygen-deprived kidney. This demonstrated that HIF-1 p
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Mailman School of Public Health study examines link between racial discrimination and substance use
3. New link between estrogen and breast cancer
4. Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Mens Health Watch
5. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
6. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
7. Researchers discover correlation between GERD and obesity in females
8. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
9. Researchers Pinpoint Link Between Caloric Restriction and Longevity
10. Link Between Air Pollution, Stroke Gets Clearer
11. No Link Between Anti-Nausea Drug, Heart Trouble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...s supporting the US Department of Defense and Fede...n Phoenix. Operation Golden Phoenix is a, four-d...gned to assist, federal, state and local agencies ...ios. Dataline is providing a vital, ad-hoc, secure...l use during the exercise., NORFOLK, Va., July 25...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...BURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmac...eutical company, today announced that it,has launc...iarrhythmic,indicated for the treatment and prophy...tion and hemodynamically unstable ventricular,tach...r heart beat.,Sagent,s amiodarone HCl injection wi...
(Date:7/25/2008)...to benefit ALS Therapy Alliance to be presented at...t, WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/...sed a record-breaking $4.4 million in just 21 days...for ALS research. This is,the seventh year of the ...ed more than $15 million for ALS research. This ye...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2
...ventricular ectopy, another name for premature hea...ound by researchers to be a better predictor of an...g exercise. Doctors from Cleveland Clinic Foundati...eart failure, valve disease or arrhythmia. They we...
...survey by the American Society of Plastic Surgeons...out their appearance, as women. They found that li...ular procedures preferred by men. More than two t...out what they would like to change about their app...
...urysm is a weakness in one of the blood vessels in...y resulting in a brain hemorrhage. Around thirty t...emorrhage in a year and they are treated surgicall... neck of the bulge. A bulge with a narrow neck is ...
... its "purest" form has no fat and no calories what...ke cream and flavoured syrup can add on to calorie...chocolate or blended coffee drinks can add up to 5...-ons and their effects on your waistline. Two tabl...
Other Medicine News:Health News:A cup of coffee could hamper your diet 2
(Date:7/23/2008)...ASPS Study Finds Some Areas of the Body Have Great...S, Ill., July 23 /PRNewswire-USNewswire/ -- Fat re...gh liposuction was found to be,an excellent source...ns,than other areas of the body, reports a Brazili...ive Surgery(R), the official medical journal of th...
(Date:7/22/2008)...BRISBANE, Australia, July 22 /PRNewswire-FirstCall...te yesterday, the Board of Progen,Pharmaceuticals ...hat it,had discontinued the PI-88 phase 3 study in...ction to develop its existing portfolio of compoun...dditional compounds and,opportunities through Merg...
(Date:7/22/2008)... FDA Meeting to Discuss Development Plan Complet...wire-FirstCall/ -- Amarin Corporation,plc (NASDAQ:... met with,officials at the U.S. Food and Drug Admi... develop AMR101 for the treatment of,hypertriglyce...is,proceeding to Phase 3 with AMR101 in hypertrigl...
(Date:7/22/2008)...EO Geoffrey Allan Will Stress the Importance to Pa...logics Approval Pathway, RICHMOND, Va., July 22 /...NSM) a developer of follow-on biologics and biopha... Ph.D., CEO of Insmed, will present at a,Congressi...s the,significant need for establishing an approva...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 1FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 2FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 3FDA Advisory Committee Unanimously Recommends U S Approval of Sugammadex the First and Only Selective Relaxant Binding Agent 1504 4WellPoint Announces Appearances at Upcoming Conferences 14092 1WellPoint Announces Appearances at Upcoming Conferences 14092 2Robbins 26 Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call 14090 1Post Op Chemo Fails to Boost Survival in Stomach Cancers 14089 1Post Op Chemo Fails to Boost Survival in Stomach Cancers 14089 2
Meter Trax Control is a whole blood quality control that can be used for glucose, hemoglobin and hematocrit testing on point of care instruments.
Liquichek Qualitative Urine Toxicology Control is a liquid control designed for use with qualitative rapid urine drug screen panels, including Point of Care (POC) Drugs of Abuse (DOA) test kits like
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates.
Liquichek Hematology-16 Control is specifically designed for use on most hematology analyzers that measure up to 16 parameters and 3-part white blood cell differentials. This trilevel control can be
Medicine Products: